focus -WSS

focus

author：comprehensive 2025-09-03 03:46:47 - browse：8

A stethoscope lays on banknotes next to a calculator, all on top of a insurance application form — coverage from STAT — Adobe

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report.

But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there. They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

Overall, private equity investors made only 4 investments in Medicare Advantage-related companies last year, compared with 12 in 2022, down from a peak of 19 in 2021, per the Private Equity Stakeholder Project, a group focused on holding private equity firms accountable for their impacts on people and the planet, according to its website.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial

WSS

Departing Stanford president retracts two papers

How a symptom of dementia informs our understanding of creativity

Apellis safety probe of eye disease drug centers on injection needle

Biotech lab space demand falls sharply

How to make Best Hospitals ratings actually useful for patients

AstraZeneca challenges Medicare drug negotiation program

hotspot

focus

explore

Tori Bowie and the unacceptable rates of Black maternal death

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

DIEP, the 'gold standard' of breast reconstruction, is under threat

Thermo Fisher plant for manufacturing gene therapies to expand

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How a symptom of dementia informs our understanding of creativity

Duchenne breakthrough therapy leaves behind pioneering families

Biotech lab space demand falls sharply

In Memoriam: Notable people who died in 2023

Senate HELP committee spars over health care workforce policies

leisure time

Departing Stanford president retracts two papers

Drug firms test therapies to halt Alzheimer’s before symptoms arise

How to make Best Hospitals ratings actually useful for patients

Senators: Long

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

CDC advisory panel says seniors 'may' get RSV vaccine

focus

explore

hotspot

hotspot